DCM
MED icon

Davidson Capital Management’s Medifast MED Stock Holding History

Davidson Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-62
Closed -$4.64K – 121
2023
Q3 		$4.64K Buy
62
+20
+48% +$1.77K ﹤0.01% 78
2023
Q2 		$3.87K Buy
42
+10
+31% +$890 ﹤0.01% 75
2023
Q1 		$3.32K Buy
32
+9
+39% +$997 ﹤0.01% 79
2022
Q4 		$2.65K Buy
23
+7
+44% +$815 ﹤0.01% 98
2022
Q3 		$2K Buy
16
+3
+23% +$430 ﹤0.01% 74
2022
Q2 		$2K Hold
13
– – ﹤0.01% 63
2022
Q1 		$2K Sell
13
-1
-7% -$189 ﹤0.01% 81
2021
Q4 		$3K Buy
+14
New +$2.89K ﹤0.01% 77
2020
Q3 		– Sell
-5
Closed -$1K – 75
2020
Q2 		$1K Hold
5
– – ﹤0.01% 65
2020
Q1 		$1K Hold
5
– – ﹤0.01% 67
2019
Q4 		$1K Buy
+5
New +$484 ﹤0.01% 52

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Davidson Capital Management's MED Position: Q4 2023 in Review

Davidson Capital Management sold out of Medifast (MED) in Q4 2023, closing a stake of 62 shares — an estimated $4.64K sold.

Davidson Capital Management first reported a position in MED in Q4 2019 and held it in 11 quarters. The position peaked at $4.64K in Q3 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Davidson Capital Management reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Davidson Capital Management sold 62 Medifast shares in Q4 2023, an estimated $4.64K.
  • Davidson Capital Management first reported a position in Medifast in Q4 2019 and held it in 11 quarters.
  • Davidson Capital Management's Medifast position peaked at $4.64K in Q3 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Davidson Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.